Growth was driven by a solid performance across speciality medicines and vaccines, including record sales for the shingles vaccine, Shingrix. In 2022, sales for the company’s pharmaceuticals and vaccines segments added up to US$36.15mn, an increase of 11% YOY. ![]() A year on and the demerger has already started to pay dividends, allowing GSK to focus purely on biopharmaceuticals, prioritising investment towards the development of innovative vaccines and speciality medicines. In July 2022, GSK completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group. Formed by the merger of Glaxo Wellcome plc and SmithKline Beecham plc in 2000, GSK specialises in fields of pharmaceutical, biologics, vaccines and consumer healthcare. UK-based multinational company, GlaxoSmithKline remains in tenth place. The top 10 pharmaceutical companies in the world in 2023 The below list of the top 10 biggest pharma companies in the world in 2023 is ranked by 2022 revenue for pharmaceutical sales only. Heading into 2022, top pharma companies had $1.7 trillion of deals in the pipeline, but many of those didn’t materialise, 2023 so far has also been lacklustre in terms of M&A activity too. Mergers and acquisitions (M&A) are also gradually changing the marketplace and some of the largest pharma companies have been strengthened through joining forces with or being bought out by other businesses. As always, the patent expirations should create quite a disturbance for many of the top players. The pharma industry in 2023 is set to face further shake-ups, many more blockbuster drugs from Johnson & Johnson, AbbVie, Roche and other companies are set to face their first generic or biosimilar competitors in the largest global pharma market, the US. However, non-NME and biosimilar approvals were up in 2022.Ī number of drug patents expired in 2022, including Bristol Myers Squibb’s Revlimid, Roche’s Lucentis, and AbbVie’s Restasis. In 2022, 37 new molecular entities were approved, a slowdown from 2021 when 42 drugs were given the green light, this was largely down to a more stringent criteria on approvals. New medications are constantly being developed, approved and marketed, powering market growth. Despite disruptions caused by the Covid-19 pandemic in recent years, pharmaceutical companies have remained agile. The pharmaceutical industry continues to grow rapidly and was valued at a remarkable US$1.48 trillion in 2022.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |